Delivery Order SPE2DB24D2205-SPE2DB25FEFJQ
- Not listed
- The Defense Logistics Agency awarded a $4,118.84 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on July 22, 2025, with ultimate completion scheduled for July 23, 2025. This contract utilizes firm fixed pricing and carries no set-aside designation, reflecting a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $15,429.77 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units). This non-competitive, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $4,297.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of July 25, 2025. This non-set-aside award was competitively procured and represents a single delivery order against AmerisourceBergen's larger contract vehicle with DLA. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ambien CR 6.25 mg tablets in a quantity of 100 units, valued at $2,148.62. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by July 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 4,568,163,597 units of Ambien CR 6.25 mg tablets, with a firm fixed price of $3,303.66 and a period of performance through May 8, 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a $3,323.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ambien CR 6.25 mg tablets. It has a completion date of June 6, 2025 and is not set aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,332.82, is for the delivery of Ambien CR 6.25 mg tablets in quantities of 100 per bottle. The contract has an ultimate completion date of May 30, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,082.73 firm fixed-price delivery order is for AMBIEN CR 6.25 MG TABLET 100S and has a completion date of February 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (SPE2DX15D3008|SPE2DX24F11JC) to AmerisourceBergen Drug Corp., a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. This $1,463.84 contract is for the delivery of Ambien CR 6.25 mg tablets to support military treatment programs and facilities. AmerisourceBergen Drug Corp. holds an indefinite delivery contract (IDC) with DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,632.06 delivery order is for Ambien CR 6.25 mg tablets, with a period of performance through February 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFJQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,248.18 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets in quantities of 100, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger contract vehicle. The pharmaceuticals will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999,999,999 global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies an extensive range of medications and medical supplies to support military healthcare programs and federal medical procurement needs. The contract demonstrates the company's capability to fulfill federal requirements for controlled pharmaceutical products across multiple therapeutic domains for defense health system customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/24/25 |